期刊文献+

西沙必利在新型键合手性柱上的拆分及其在血浆中的含量测定 被引量:1

Separation and Quantitative Determination of Cisapride Enantiomers on a New Cellulose Bonded Chiral Stationary Phase
下载PDF
导出
摘要 建立一种用新型键合纤维素手性固定相拆分西沙必利对映体的高效液相色谱方法,并利用此方法测定血浆中西沙必利的含量.使用Chiralpak IC色谱柱(250 mm×4.6 mm,5μm),流动相为正己烷-异丙醇-二乙胺(体积比80∶ 20∶0.1),流速0.8 mL/min,检测波长273 nm,柱温25℃.取血浆200 μL,加入西沙必利标准溶液10 μL,碱化后用正庚烷-异戊醇(体积比95∶5)提取,40℃氮气吹干.结果表明:西沙必利对映体在新型键合直链纤维素衍生化合物手性固定相上能够完全分离,分离度为1.65;其血浆提取回收率达87%,线性范围为10~ 160 μg/mL,最低检测限为5 μg/mL,RSD<4.0%.本方法可方便地实现西沙必利对映体的分离及其在血浆中的含量测定,为临床上西沙必利的血药浓度监测及药代动力学研究提供了便捷、灵敏的分析手段. A liquid chromatographic method for the chiral separating enantiomers of cisapride in plasma was developed.Cisapride enantiomers were separated and determinated by a Chiralpak IC chiral column (250 mm ×4.6 mm,5 μm) at 25 ℃ and detected at 273 nm,the mobile phase used was n-hexane-isopropanol (80∶ 20,0.1% DEA) at a flow rate of 0.8 mL/min.Alkalinized samples of plasma (200 μL) were extracted with n-heptane-isopentanol (95∶ 5).The organic phase was evaporated to dryness under nitrogen at 40 ℃.The results showed that cisapride enantiomers were separated on a new cellulose bonded chiral stationary phase and the resolution was 1.65.The mean extraction efficiency was 87%.Calibration plots in rat plasma were linear from 10 to 160 μg/mL.The limit of detection was 5 μg/mL and RSD <4.0%.The present method could be easily used for separating the enantiomers of cisapride and determination of cisapride enantiomers in plasma.It provided a new approach for the determination of plasma concentration and its pharmacokinetic studies.
出处 《郑州大学学报(理学版)》 CAS 北大核心 2014年第2期93-98,共6页 Journal of Zhengzhou University:Natural Science Edition
关键词 高效液相色谱法 Chiralpak IC手性柱 对映体分离 西沙必利 含量测定 血浆 HPLC Chiralpak IC chiral column enantiomeric separation cisapride quantitative determination plasma
  • 相关文献

参考文献16

  • 1Eiehelbaum M. Pharmacokinetic and pharmacodynamic consequences of stereoselective drug metabolism in man [ .1 ]. Biochem Pharmacol, 1988,37( 1 ) :93 -96.
  • 2McCallum R W, Prakash C, Campoli-Richards D M, eta|. Cisapride : a preliminary review of its pharmacodynamic and phar- macokinetie properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders [ J ]. Drugs, 1988,36 (6) : 652 - 681.
  • 3Vandenplas Y. Clinical use of cisapride and its risk-benefit in paediatric patients [ J]. Eur J Gastroenterol Hepalol, 1998,10 (10) :871 -881.
  • 4Desta Z, Kivisto T K, Lilja J J, eta|. Stereoselective pharmacokinetics of cisapride in healthy wlunteers and the effect of re- peated administration of grapefruit juice[ J ]. Br J Clin Pharmacol, 2001, 52 (4) : 399 - 407.
  • 5Wysowski D K, Bacsanyi J. Cisapride and fatal arrhythmia[ J]. New Engl J Med, 1996, 335 (4) : 290 -291.
  • 6Bedford T A, Rowbntham D J. Cisapride: drug interactions of clinical significance[J]. Drug Saf, 1996, 15(3) :167 -175.
  • 7Thomas A R, Chan L N, Bauman J L, et al. Prolongation of the QT interval related to cisapride-diltiazem interaction [ J ]. Phar- macotherapy, 1998, 18 (2) : 381 - 385.
  • 8Haarst A D, Klooster G, Gerven J M, et al. The influence of cisapride and elarithromyein on QT intervals in healthy w)lunteers [ J ]. Clin Pharmacol Ther, 1998, 64 (5) :542 - 546.
  • 9Sastry C, Srinivas Y, Ran P. Assay of cisapride in pharmaceutical formulations by visible spectrophotometry[ J]. Microchimica Acta, 1997, 126(1/2) : 63 -67.
  • 10Sastry C, Srinivas Y, Rao P, et al. Assay of cisapride in pharmaceutical formulations by extraction spectrophotometry [ J ]. Ta- lanta, 1997,44(4) :517 -526.

二级参考文献22

  • 1农容丰,吴强,王恒山,林宁,潘英明,谢建武.溴代脱氢松香酸结构和构象的NMR研究[J].广西师范大学学报(自然科学版),2004,22(3):58-61. 被引量:7
  • 2程介克.高效液相色谱分光光度测定痕量金属[J].高等学校化学学报,1995,16(5):696-703. 被引量:25
  • 3徐学军,张华山,张传铀,程介克.高效液相色谱光度法测定痕量铜、锌、铁、锰的磺化四苯基卟啉配合物[J].高等学校化学学报,1990,11(9):947-951. 被引量:33
  • 4UEHARA N,JINNO K I,HASHIMOTO M,et al.Recents Application of High-Performance Liquid Chromatography to the Analysis of Metal Complexes[J].J Chromatogr A(S 0021-9673),1997,789(2):395-399.
  • 5ROBARDS K,STARR P,PATSALIDES E.Metal Determination and Metal Speciation by Liquid Chromatography[J].Analyst(S 0003-2654),1991,116(9):1247-1251.
  • 6HU Q F,YANG G Y,YIN J Y,et al.Determination of Trace Lead,Cadmium and Mercury by on-line Column Enrichment followed by RP-HPLC as Metal-tetra-(4-bromophenyl)-porphyrin chelates[J].Talanta(S 0039-9140),2002,57:751-756.
  • 7MAICKEL R P. Nonsteroidel anti-inflammatory drugs[J]. Neuropharmecol, 1982,21 : 1329.
  • 8LEWIS N M ,CRAIG M W. Oxidative degradation of benzene rings[J]. Tetrahedron, 2003,59:1105-1136.
  • 9LIU Yi-ming,MIAO Jian-rong,TOYOOKA T. Enantiometric separation of di: and tri-peptides with chiral fluorescence labeling reagents [J]. Anal Chim Acta, 1995,314 : 169-173.
  • 10ZHAO Shu-lin,ZHANG Reng-can,WANG Heng-shan. Capillary electrophoresis enantioselective separation of vigabatrin enantiomers by precolumn derivatization with dehydroabietyl isothioeyante and UV-vis detection[J]. J Chromatogr B, 2006,833 : 186-190.

共引文献14

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部